Gaudium IVF is entering the public markets through Mainboard IPO with an issue size of ₹165.00 crore. The issue consists of a fresh issue of ₹90.00 crore and an offer for sale of ₹75.00 crore. The shares are proposed to be listed on NSE & BSE.
The IPO subscription window opens on February 20, 2026 and will remain open until February 24, 2026. The company plans to list its shares on February 27, 2026. Since this is a Mainboard IPO, participation is expected from a wide range of investors.
Gaudium IVF and Women Health Limited IPO Timeline
IPO Quick Facts
This section covers the main IPO details of Gaudium IVF that investors generally review before applying.
IPO Details at a Glance
| Company Name | Gaudium IVF |
|---|---|
| IPO Segment | Mainboard |
| Sale Type | Fresh Issue + Offer For Sale |
| Issue Type | Bookbuilding IPO |
| Price | ₹75 – ₹79 Per Share |
| Lot Size | 189 Shares |
| Face Value | ₹5 Per Share |
| Exchange | NSE & BSE |
IPO Documents
| RHP | DRHP |
|---|---|
|
|
Gaudium IVF IPO Important Dates
The following table highlights the key dates for the Gaudium IVF IPO, covering the subscription period and the expected listing timeline.
| IPO Opening Date | 20 Feb 2026 |
|---|---|
| IPO Closing Date | 24 Feb 2026 |
| Allotment Finalization | 25 Feb 2026 |
| Initiation of Refunds | 25 Feb 2026 |
| Credit of Shares | 26 Feb 2026 |
| IPO Listing Date | 27 Feb 2026 |
Gaudium IVF IPO Size & Structure
| Total IPO Size | ₹165.00 Crore |
|---|---|
| Offer For Sale | ₹75.00 Crore |
| Fresh Issue | ₹90.00 Crore |
Gaudium IVF and Women Health IPO Lot Size & Minimum Investment
The table below shows the lot size and investment amount for the Gaudium IVF and Women Health IPO, calculated using the cut-off price. The price band for this IPO ranges from ₹75 to ₹79 per share.
Investors can apply for the IPO with a minimum of 189 shares. Applications must be made in multiples of 189 shares.
- Retail investors can apply from 1 lot to 13 lots.
- Small HNI (SHNI) investors must apply for at least 14 lots.
- Big HNI (BHNI) investors need to apply for a minimum of 67 lots.
This information helps investors understand the minimum investment required before applying for the IPO.
Note: Retail investors generally apply at the cut-off price, which is ₹79 per share.
| Category | Lots | Shares | Price | Amount |
|---|---|---|---|---|
| Retail (Min) | 1 | 189 | ₹79 | ₹14,931 |
| Retail (Max) | 13 | 2,457 | ₹79 | ₹194,103 |
| S-HNI (Min) | 14 | 2,646 | ₹79 | ₹209,034 |
| S-HNI (Max) | 66 | 12,474 | ₹79 | ₹985,446 |
| B-HNI | 67 | 12,663 | ₹79 | ₹1,000,377 |
Gaudium IVF IPO GMP (Grey Market Premium)
The latest Gaudium IVF IPO GMP (Grey Market Premium), along with Kostak rates and Subject to Sauda rates, helps in understanding market sentiment. The current Gaudium IVF IPO GMP is ₹8 (10.13%), compared to the IPO issue price of ₹79. Based on the current GMP, the expected listing price is around ₹87. The Lowest GMP was ₹0 on 16 Feb 2026, while the highest GMP reached ₹10 on 19 Feb 2026.
Gaudium IVF IPO is expected to be listed on the stock exchange on 27 Feb 2026. The IPO has been subscribed 0.91 times so far. The first reported GMP was ₹0 (0%), while the latest available GMP stands at ₹8 (10.13%).Gaudium IVF IPO GMP Today - Trend Analysis
| Date | Issue Price (₹) | GMP Price (₹) | Estimated Gain (%) | Estimated Price (₹) | Estimated Profit (₹) |
|---|---|---|---|---|---|
| 21 Feb 2026 | ₹79 | ₹8 | 10.13% | ₹87 | ₹1,512 |
| 20 Feb 2026 | ₹79 | ▼ ₹8 | ▼ 10.13% | ₹87 | ₹1,512 |
| 19 Feb 2026 | ₹79 | ₹10 | 12.66% | ₹89 | ₹1,890 |
| 18 Feb 2026 | ₹79 | ₹10 | 12.66% | ₹89 | ₹1,890 |
| 17 Feb 2026 | ₹79 | ▲ ₹10 | ▲ 12.66% | ₹89 | ₹1,890 |
| 16 Feb 2026 | ₹79 | ₹0 | 0% | ₹79 | ₹0 |
| 14 Feb 2026 | ₹79 | ₹0 | 0% | ₹79 | ₹0 |
| 13 Feb 2026 | ₹79 | ₹0 | 0% | ₹79 | ₹0 |
Gaudium IVF IPO GMP gives retail and institutional investors an idea about short-term market expectations. Although grey market premium does not guarantee listing performance, it is still commonly referred to while analysing IPOs. Investors are advised to look at Gaudium IVF fundamentals along with IPO GMP data before making any investment decision.
GMP Disclaimer: GMP (Grey Market Premium) prices are unofficial and only reflect market sentiment. We neither participate in grey-market trading nor encourage it. Investors are strongly advised to review the company’s fundamentals, risks, and official documents before considering an investment in the Gaudium IVF IPO.
Gaudium IVF IPO Subscription Status
Gaudium IVF IPO was subscribed 0.91 times overall on the final day of bidding (as of 20 Feb 2026).The subscription opened on 20 Feb 2026. The Retail portion was subscribed 1.43 times, while NII categories were subscribed 0.91 times.
Subscription by Category (QIB, NII, Retail, Employee)
Daily Subscription Trend (Day-wise):
| Date | QIB | NII | Retail | Employee | Total |
|---|---|---|---|---|---|
| 20 Feb 2026 | — | 0.91x | 1.43x | — | 0.91x |
On Day-1, the Gaudium IVF IPO saw low participation from investors. Retail subscription remained limited at 1.43x, while NII interest was also weak, keeping overall subscription on the lower side.
Gaudium IVF IPO Final Subscription
| Category | Subscription |
|---|---|
| Qualified Institutional Buyers (QIB) | — |
| Non-Institutional Investors (NII) | 0.91x |
| Retail Investors | 1.43x |
| Total | 0.91x |
Gaudium IVF IPO Allotment Status
The Gaudium IVF IPO allotment status has not been announced yet. It will be declared on 25 Feb 2026. Please check back in 3 days for the allotment results.
- 🗓 Allotment Date: 25 Feb 2026
- 📈 Listing Date: 27 Feb 2026
How to Check Gaudium IVF IPO Allotment Status Online?
Investors can check the Gaudium IVF IPO allotment status online through BigShare Services Private Limited, NSE and BSE websites. All platforms provide easy access to the IPO allotment details.
Just follow the below mentioned steps to check your allotment status.You can also visit
BigShare Services
to know more about the IPO registrar.
Check on BigShare Services Private Limited (IPO Registrar)
- Visit → BigShare Services Private Limited
- Select Gaudium IVF
- Select Application No / CAF No / Beneficiary ID / PAN Number
- Enter the relevant details and CAPTCHA to proceed further
- Click Search to view allotment status
Check on NSE (National Stock Exchange) Website
- Go to → NSE Website
- Select Equity & SME IPO Bid Details.
- Choose Gaudium IVF IPO.
- Enter your PAN & Application Number.
- Click on Submit button.
The National Stock Exchange (NSE) provides an online facility to check the Gaudium IVF IPO allotment status.
Check on BSE (Bombay Stock Exchange) Website
- Visit → BSE Website.
- Select Issue Type: Equity.
- Choose Gaudium IVF IPO.
- Enter your PAN or Application Number.
- Click on Search button.
The Bombay Stock Exchange (BSE) also allows investors to check the Gaudium IVF IPO allotment status online.
Note: Allotment status is published only on the official registrar websites. We do not collect investor data or provide allotment verification directly.
How to Apply for Gaudium IVF IPO?
Login to Your Trading App
Open your trading app such as Angel One, Zerodha, Upstox, Groww or any brokerage app.
Go to the IPO Section
Navigate to the IPO section in the app, search for the IPO, and enter your bid details.
Enter Your UPI ID
Provide your UPI ID that is linked to your bank account for payment authentication.
Approve the Mandate
Open your UPI app and approve the payment mandate to block the required amount.
Application Confirmation
Application submitted successfully, the funds will remain blocked until allotment is finalized.
About Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited Incorporated in the year 2015, Gaudium IVF and Women Health is engaged in IVF (In vitro fertilisation) treatment in India and has grown into several states with the Hub and spoke model over the years.
Gaudium IVF is founded by their promoter Dr. Manika Khanna, a specialist with advanced training in gynaecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited.
The company has a PAN India presence.
IPO Financial Summary
- Total Assets changed by 73.51% in FY 2024-2025.
- Total Revenue changed by 47.37% in FY 2024-2025.
- Profit After Tax changed by 85.37% in FY 2024-2025.
- Reserves & Surplus changed by -40% in FY 2024-2025.
- Total Borrowings changed by 20.34% in FY 2024-2025.
| Metric | 2025-09-30 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets (₹ Cr) | 106.62 | 88.51 | 51.01 | 36.63 |
| Total Revenue (₹ Cr) | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax (₹ Cr) | 12.51 | 19.13 | 10.32 | 13.53 |
| Reserves & Surplus (₹ Cr) | 28.16 | 15.60 | 26.00 | 21.74 |
| Total Borrowings (₹ Cr) | 22.51 | 18.93 | 15.73 | 9.78 |
Utilisation of Proceeds
The Company proposes to utilise the net IPO proceeds of approximately ₹140.00 crore towards the following objectives:
| # | Purpose | Amount (₹ Cr) | % of Total |
|---|---|---|---|
| 1 | Funding capital expenditure towards establishment of New IVF Centers of the Company. | 50.00 | 35.71% |
| 2 | Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. | 20.00 | 14.29% |
| 3 | Total | 70.00 | 50.00% |
| Total | 140.00 | 100% | |
Gaudium IVF and Women Health IPO Promoter Holding
| Promoter(s) | Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna |
|---|---|
| Pre-Issue Holding | 99.99% |
| Post-Issue Holding | 71.30% |
Gaudium IVF IPO FAQs
The Gaudium IVF IPO is a Mainboard Bookbuilding IPO with a total issue size of ₹165.00 crore. The issue consists of a fresh issue of ₹90.00 crore and an offer for sale of ₹75.00 crore.
The IPO will open for subscription on Fri, 20 Feb 2026 and will close on Tue, 24 Feb 2026.
The shares are being offered at a price band of ₹75 to ₹79 per equity share.
Investors can apply for the IPO with a minimum lot size of 189 shares.
At the upper price band, the minimum investment required for one lot is approximately ₹14,931.
The shares of Gaudium IVF are expected to be listed on NSE & BSE on Fri, 27 Feb 2026.
The Grey Market Premium (GMP) of Gaudium IVF IPO is ₹8.
The expected listing price of Gaudium IVF IPO is around ₹87 based on current GMP. This indicates a potential return of approximately 10.13% , with an estimated profit of ₹1,512 per lot, subject to market conditions.
The Gaudium IVF IPO was subscribed 0.91 times on the final day of subscription.
The retail portion is subscribed 1.43 times as of 20 Feb 2026.
the NII portion is subscribed 0.91 times .
The IPO registrar of Gaudium IVF is BigShare Services Private Limited. BigShare is responsible for processing IPO applications, finalizing allotment, crediting shares, and initiating refunds.
The allotment date is expected on Wed, 25 Feb 2026.
Allotment status is generally updated in the evening (6 PM – 10 PM) on Wed, 25 Feb 2026 on the registrar or exchange website.
Shares are expected to be credited by Thu, 26 Feb 2026.
Refunds for unsuccessful applicants will be initiated on Wed, 25 Feb 2026.
Investors can check refund status via:
- UPI mandate / bank account (NACH, NEFT, RTGS)
- ASBA bank portal
Listing details for Gaudium IVF and Women Health Limited are not available.
The latest share price of Gaudium IVF and Women Health Limited is currently not available.
Recent price movement data for Gaudium IVF and Women Health Limited is currently not available.
Disclaimer: The content published on this website is for informational and educational purposes only and must not be treated as financial, trading or investment advice. Share Market related articles, IPO details, GMP values, subscription data, listing estimates, allotment status and related information reflect market sentiment and public data and may be inaccurate or outdated. Nothing on this website constitutes an offer or recommendation to buy or sell any securities. We are not SEBI registered financial advisors. Investors must consult a qualified SEBI registered financial advisor before making any investment decisions. Any investment made based on the information provided here is entirely at the reader’s own risk. The author and the team at TheFinancialTalks.com shall not be responsible or liable for any financial loss. Investors must conduct thorough due diligence and seek professional financial advice before making any investment decisions.